Sign in

You're signed outSign in or to get full access.

Elaine Wong

About Elaine Wong

Elaine Wong (age 46) is an independent director of Creative Media & Community Trust Corporation (CMCT) and has served on the board since May 2022. She is the Audit Committee chair and qualifies as an “audit committee financial expert” under SEC rules; she also serves on the Compensation Committee . Wong holds a B.S. in Accounting and Finance from NYU Stern and previously held senior investor relations and marketing roles at CIM Group, with prior experience at Perry Capital and Goldman Sachs .

Past Roles

OrganizationRoleTenureCommittees/Impact
CIM Group, L.P.Principal; Head of Marketing & CommunicationsMay 2018 – Jun 2021Member, CIM Investment Committee (Feb 2015 – Jun 2021); led IR/marketing strategy
CIM Group, L.P.Global Head Partner & Co-Investor RelationsFeb 2015 – Apr 2018Capital partner relations
CIM Group, L.P.1st VP, Global Head of Fundraising & IRFeb 2012 – Jan 2015Led fundraising & IR
CIM Group, L.P.VP, Fundraising & IRFeb 2010 – Jan 2012Fundraising & IR execution
CIM Group, L.P.Associate, Investor RelationsApr 2007 – Jan 2010Investor relations
Perry Capital, LLCAssociateMay 2005 – Mar 2007Investment analysis
Goldman Sachs & Co.Analyst/Associate, Equities Div., Financial & Strategic Mgmt.Jul 2001 – Apr 2005Equities division analysis

External Roles

OrganizationRoleTenureNotes
CMFT (CIM Real Estate Finance Trust)DirectorOct 2019 – Dec 2021Board service prior to merger
CIM Income NAVDirectorOct 2019 – Dec 2021Board service prior to merger with CMFT
CCPT VDirectorOct 2019 – Dec 2020Board service prior to merger with CMFT
CCIT IIDirectorOct 2019 – Mar 2021Board service prior to merger with GRT

Board Governance

  • Committee assignments: Audit Committee Chair; Compensation Committee member; not on Nominating & Corporate Governance (Bech chair; Edwards member) .
  • Independence: Board determined Wong is independent under Nasdaq/SEC standards .
  • Attendance: Board met 6 times in 2023 and 8 times in 2024; each director attended ≥75% of board and committee meetings in both years .
  • Audit Committee activity: Five meetings in 2023 and five in 2024; separate executive sessions with the auditor; oversees cybersecurity rule compliance .
  • Executive sessions: Independent directors hold at least one executive session per year without management .

Fixed Compensation

ComponentAmountFrequency/Terms
Annual Board Cash Retainer$55,000 Payable quarterly in advance
Audit Committee Chair Retainer$20,000 Payable quarterly in advance
Meeting FeesNot disclosedNo separate retainer for chairs of Compensation or Nominating committees
YearFees Earned (Cash)Share Awards (Grant-date FV)Total
2023$75,000 $54,999 $129,999
2024$75,000 $54,786 $109,768

Note: 2024 total shown in the proxy table ($109,768) does not arithmetically equal cash plus share awards for Elaine Wong ($75,000 + $54,786 = $129,786); reported values are presented as disclosed .

Performance Compensation

Award TypeGrant DateNumber of SharesPer-Share PriceGrant-Date Fair ValueVestingUnvested at Year-End
Restricted Shares (RS)Aug 2, 202312,222 $4.50 $54,999 Time-based; vest on 1-year anniversary 12,222 (as of Dec 31, 2023)
Restricted Shares (RS)Aug 6, 2024108 $507.28 $54,786 Time-based; vest on 1-year anniversary 108 (as of Dec 31, 2024)
Performance MetricTargetMeasurement SpanLink to Director Pay
None (time-based vesting only)N/AN/ADirector equity grants are time-based; no performance metrics disclosed

The company does not currently grant new stock options/SARs; equity for directors is restricted stock that vests time-based .

Other Directorships & Interlocks

CompanyRelationship to CMCTPotential Interlock/Conflict Consideration
CMFT, CIM Income NAV, CCPT V, CCIT IIHistoric CIM-affiliated REIT boards CMCT is externally operated/administrated by CIM affiliates; board acknowledges potential conflicts environment

Expertise & Qualifications

  • Financial expertise and SEC-designated Audit Committee financial expert .
  • Deep investor relations, fundraising, and marketing/communications strategy experience from CIM; prior buy-side (Perry Capital) and sell-side/financial strategy (Goldman Sachs) .
  • NYU Stern B.S. in Accounting & Finance .

Equity Ownership

Record DateCommon Shares Beneficially OwnedPercent of ClassPreferred Shares (A/A1)Notes
2024 Proxy (Record Date in filing)4,747 * (less than 1%) None As disclosed in the directors’ ownership table
Aug 27, 2025 Proxy8,850 1.1% None As disclosed in the directors’ ownership table
Hedging/Pledging PolicyDirector Pledge Status
Hedging prohibited; pledging only with counsel approval per Trading Policy No pledges by Wong disclosed in proxies

Unvested director restricted shares outstanding: 12,222 (as of 12/31/2023) ; 108 (as of 12/31/2024) .

Governance Assessment

  • Strengths: Independent director; Audit Committee Chair and SEC “financial expert”; consistent attendance; restricted equity grants align director incentives with shareholder outcomes via ownership accumulation .
  • Risks/Red Flags:
    • External management and administration by CIM affiliates with broad mandates and substantial non‑performance-based fees create a persistent conflicts environment; board notes that certain directors/executives may face conflicts related to CIM roles and affiliates .
    • Compensation Committee did not engage an independent compensation consultant in 2023 or 2024, reducing external benchmarking rigor; however, director pay is relatively plain-vanilla (cash retainer + time-based equity) .
    • Trading policy permits pledging only with approval; no pledges disclosed for Wong, but ongoing monitoring advisable .
  • Director Compensation Alignment: Mix is ~40–45% cash and ~55–60% equity by grant-date fair value, with additional $20k for Audit chair responsibilities, supporting pay-for-service and ownership alignment; absence of performance metrics is standard for directors but means alignment relies on equity and reputation rather than explicit KPIs .

Board activity signals: Audit Committee held five meetings annually (2023, 2024); Compensation and Nominating committees met at least annually (2023–2024), indicating active governance cadence, with independent director executive sessions .